These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24519658)

  • 21. Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.
    Bruno VA; Fox SH; Mancini D; Miyasaki JM
    Can J Neurol Sci; 2016 Sep; 43(5):697-702. PubMed ID: 27514242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
    Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
    Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A in non-dystonic tremors.
    Henderson JM; Ghika JA; Van Melle G; Haller E; Einstein R
    Eur Neurol; 1996; 36(1):29-35. PubMed ID: 8719647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual position-sensitive jaw tremor responsive to botulinum toxin.
    Tarsy D; Ro SI
    Mov Disord; 2006 Feb; 21(2):277-8. PubMed ID: 16211606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
    Papapetropoulos S; Singer C
    Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.
    Lew MF; Brashear A; Factor S
    Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
    Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
    Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robot-mediated and clinical scales evaluation after upper limb botulinum toxin type A injection in children with hemiplegia.
    Frascarelli F; Masia L; Di Rosa G; Petrarca M; Cappa P; Castelli E
    J Rehabil Med; 2009 Nov; 41(12):988-94. PubMed ID: 19841830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.
    Rosales RL; Kanovsky P; Fernandez HH
    Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S3-10. PubMed ID: 21999894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin therapy: functional silencing of salivary disorders.
    Lovato A; Restivo DA; Ottaviano G; Marioni G; Marchese-Ragona R
    Acta Otorhinolaryngol Ital; 2017 Apr; 37(2):168-171. PubMed ID: 28516981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
    Quirk JA; Sheean GL; Marsden CD; Lees AJ
    Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A for treating voice tremor.
    Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
    Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.